Scientists have found that glucose plays a significant role in how the brain functions.

Published Date: 26 Apr 2023

Nearly a quarter of the body's sugar energy, or glucose, is consumed daily by the human brain, which also has a sweet tooth. Now, scientists from the Gladstone Institutes and UC San Francisco (UCSF) have provided fresh insight into how.

Read Full News

Latest News

US Cancer Clinics Scramble to Get Experimental Revolution Medicines Pancreatic Cancer Drug

U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer drug from Revolution Medicines while they await...

Implanted Islet Cell Device Could Control Glucose for Weeks

Researchers developed a battery-free device the size of a coin that can deliver islet cells in the body and keep them healthy, no immunosuppression required.

Blame for the Obesity Epidemic Falls on Food Industry

The rise of new weight-loss drugs could help reframe obesity as a societal failure driven by the food industry, rather than an individual failing rooted in lack of willpower.

Can GLP-1 Drugs Improve Breast Cancer Survival?

A ‘big’ data study links the diabetes and weight-loss drugs to better long-term survival after breast cancer. Critics are unconvinced.

EyePoint's Late-stage Eye Drug Trials to Continue After Safety Panel Review

EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials ⁠of its experimental eye disease drug Duravyu and recommended the...

Can Gut Bacterium Supplement Lead to Less Weight Regain?

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Latest News

U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer drug from Revolution Medicines while they await...

Researchers developed a battery-free device the size of a coin that can deliver islet cells in the body and keep them healthy, no immunosuppression required.

The rise of new weight-loss drugs could help reframe obesity as a societal failure driven by the food industry, rather than an individual failing rooted in lack of willpower.

A ‘big’ data study links the diabetes and weight-loss drugs to better long-term survival after breast cancer. Critics are unconvinced.

EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials ⁠of its experimental eye disease drug Duravyu and recommended the...

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

News All Time

Hidden Sugar Traps Patients With Diabetes Should Recognize

Food labels are often misleading when it comes to glycemic impacts.

Oral Orforglipron Effective in Older Adults With Obesity

People over 65 taking once-daily oral orforglipron achieved substantial weight loss with a consistent safety profile, regardless of T2D status, in a post hoc ATTAIN trial analysis.

Refining Management Strategies for Patients With Endometriosis

Refining Management Strategies for Patients With Endometriosis

Toddler Has Menstrual Cycle at 17 Months

Clinicians ruled out precocious puberty before landing on a diagnosis of exclusion

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Accurate and Timely Diagnosis of Endometriosis

Accurate and Timely Diagnosis of Endometriosis

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Doctors Urge Women to Be Wary of Marketing Surge in Menopause Products

"It really pays to be very, very, very skeptical," says one expert

Many Older Patients Can Ditch Common Thyroid Drug, Study Suggests

Experts call for better guidance on levothyroxine initiation, deprescribing

GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics

News and commentary from the endocrinology world

Further Doubt on Heart-Healthiness of Calcium Supplements

Recurrent cardiovascular events increased in a large cohort study

Drug Manufacturer Coupon Use; Cholesterol Targets for Secondary Prevention

Also in TTHealthWatch: deprescribing levothyroxine

Are GLP-1 Drugs Linked to Erectile Dysfunction?

Real-world study in type 2 diabetes suggests possible association, but more research is needed

Call to Integrate Obesity Management With Surgery, GLP-1s Into Cancer Care

"Most effective therapies" underutilized, say authors, but oncologist cites lack of quality data

Recommended News For You

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

Watch for Psoriasis After Cancer Immunotherapy, Study Says

Future of Lab-Developed Tests Still Taking Shape

UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts

New protein target discovered for childhood medulloblastomas

Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

Recommended Articles For You

Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning 

Cracking Oncology Drug Resistance: New Strategies to Overcome Challenges in Modern Cancer Therapy 

Beyond Immunotherapy: Emerging Novel Treatments for Small Cell Lung Cancer 

Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.

2.

The Effect of Common Steroids on Cancer Treatments.

3.

Study sheds light on challenges for women of color after breast cancer surgery

4.

In women with extremely dense breasts, elevated MRI enhancement can help identify cancer risk.

5.

Research discovery halts childhood brain tumor before it forms

1.

The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia

2.

Polyposis Syndrome: Causes, Symptoms, and Treatment Options

3.

Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients

4.

IL1R2 Inhibition: A New Strategy to Boost Cancer Immunity

5.

Unveiling the Hidden Benefits of Lymphedema Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

3.

Navigating the Complexities of Ph Negative ALL - Part XIII

4.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

5.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot